PDF下载 ( 3096 KB)
Vater壶腹神经内分泌瘤合并胃肠道间质瘤1例报告
DOI: 10.3969/j.issn.1001-5256.2022.05.033
伦理学声明：本例报告已获得患者知情同意。
利益冲突声明：所有作者均声明不存在利益冲突。
作者贡献声明：吴政奇负责查阅文献，撰写论文; 仇晓桐负责采集图片，对文章进行修改; 吕国悦负责指导撰写文章并最后定稿。
Vater ampulla neuroendocrine tumor with gastrointestinal stromal tumor: A case report
-
-
Key words:
- Ampulla of Vater /
- Neuroendocrine Tumors /
- Gastrointestinal Stromal Tumors
-
图 1 腹部增强CT结果
注：a，NET动脉期(箭头所示); b，NET门静脉期(箭头所示); c，NET延迟期(箭头所示); d，GIST动脉期(箭头所示); e，GIST门静脉期(箭头所示); f，GIST延迟期(箭头所示)。
Figure 1. Abdominal contrast-enhanced CT manifestations
图 2 病理及免疫组化结果
注：a，HE染色(×200);b，CgA染色(×100);c，Syn染色(×100); d，CD117(×100)。
Figure 2. Pathological and immunohistochemical manifestations
-
[1] HALLET J, LAW CH, CUKIER M, et al. Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes[J]. Cancer, 2015, 121(4): 589-597. DOI: 10.1002/jhbp.415. [2] ABUDUREYIMU TEH, DENG Y, WANG K, et al. A case of neuroendocrine tumor of the ampulla of Vater[J]. J Clin Hepatol, 2019, 35(3): 621-622. DOI: 10.3969/j.issn.1001-5256.2019.03.037.阿不都热依木·吐尔洪, 邓毓, 王琨, 等. Vater壶腹神经内分泌肿瘤1例报告[J]. 临床肝胆病杂志, 2019, 35(3): 621-622. DOI: 10.3969/j.issn.1001-5256.2019.03.037. [3] DASARI A, SHEN C, HALPERIN D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol, 2017, 3(10): 1335-1342. DOI: 10.1001/jamaoncol.2017.0589. [4] ZHENG BW, WANG CL, LIU H, et al. Primary large cell neuroendocrine carcinoma of the ampulla of Vater: A case report[J]. J Clin Hepatol, 2020, 36(11): 2550-2552. DOI: 10.3969/j.issn.1001-5256.2020.11.034.郑博文, 王传磊, 刘欢, 等. 原发十二指肠壶腹大细胞神经内分泌肿瘤1例报告[J]. 临床肝胆病杂志, 2020, 36(11): 2550-2552. DOI: 10.3969/j.issn.1001-5256.2020.11.034. [5] Gastrointestinal Hormone and Neuroendocrine Neoplasm Group, Chinese Society of Gastroenteroloy, Chinese Medical Association. Expert consensus on diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm (2020, Guangzhou)[J]. Chin J Dig, 2021, 41(2): 76-87. DOI: 10.3760/cma.j.cn311367-20210104-00007.中华医学会消化病学分会胃肠激素与神经内分泌肿瘤学组. 胃肠胰神经内分泌肿瘤诊治专家共识(2020·广州)[J]. 中华消化杂志, 2021, 41(2): 76-87. DOI: 10.3760/cma.j.cn311367-20210104-00007. [6] XU JM, LIANG HJ, QIN SK, et al. Expert consensus on gastrointestinal pancreatic neuroendocrine tumors in China (2016 edition)[J]. J Clin Oncol, 2016, 21(10): 927-946. DOI: 10.3969/j.issn.1009-0460.2016.10.013.徐建明, 梁后杰, 秦叔逵, 等. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版)[J]. 临床肿瘤学杂志, 2016, 21(10): 927-946. DOI: 10.3969/j.issn.1009-0460.2016.10.013. [7] KARAGIANNIS S, ESHAGZAIY K, DUECKER C, et al. Endoscopic resection with the cap technique of a carcinoid tumor in the duodenal bulb[J]. Endoscopy, 2009, 41(Suppl 2): E288-289. DOI: 10.1055/s-0029-1215123. [8] PAVEL M, O'TOOLE D, COSTA F, et al. ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site[J]. Neuroendocrinology, 2016, 103(2): 172-185. DOI: 10.1159/000443167. [9] NILSSON B, BVMMING P, MEIS-KINDBLOM JM, et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden[J]. Cancer, 2005, 103(4): 821-829. DOI: 10.1002/cncr.20862. [10] HOHENBERGER P, EISENBERG B. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST)[J]. Ann Surg Oncol, 2010, 17(10): 2585-2600. DOI: 10.1245/s10434-010-1053-9. [11] LIN YL, WEI CK, CHIANG JK, et al. Concomitant gastric carcinoid and gastrointestinal stromal tumors: A case report[J]. World J Gastroenterol, 2008, 14(39): 6100-6103. DOI: 10.3748/wjg.14.6100. [12] SAMARAS VD, FOUKAS PG, TRIANTAFYLLOU K, et al. Synchronous well differentiated neuroendocrine tumour and gastrointestinal stromal tumour of the stomach: A case report[J]. BMC Gastroenterol, 2011, 11: 27. DOI: 10.1186/1471-230X-11-27 -
下载:
本文二维码
图(3)
计量
- 文章访问数: 428
- HTML全文浏览量: 83
- PDF下载量: 30
- 被引次数: 0
